INHSU 2023

17-20 October 2023

International Convention Centre, Geneva, Switzerland
+ virtual on-demand

The 11th International Conference
on Health and Hepatitis
in Substance Users

Register now

 

INHSU 2023 Reviewers

 

We would like to thank all reviewers for INHSU 2023:

  • Emily Adamson, Burnet Institute, Australia
  • Aniedi Akpan, Drug Free And Preventive Healthcare Organization (DAPHO), Nigeria
  • Luis Alfonso, PAHO
  • Stephen Barclay, Glasgow Royal Infirmary, United Kingdom
  • Sofia Bartlett, BC Centre for Disease Control, Canada
  • Mia Biondi, York University, Canada
  • Matt Bonn, Canadian Association of People Who Use Drugs (CAPUD), Canada
  • Philip Bruggmann, Arud, Centre for Addiction Medicine, Switzerland
  • Christopher Byrne, University Of Dundee, Scotland
  • Joaquin Cabezas, University Hospital Marques De Valdecilla, Spain
  • Erika Castro Batänjer, Cabinet de groupe Dr Castro et Dr Koffi-Blanchard, Suisse
  • Javier Cepeda, Johns Hopkins Bloomberg School of Public Health
  • Justin Chan, Correctional Health Services, Nyc Health + Hospitals, United States
  • Monica Ciupagea, UNODC, Romania
  • Samantha Colledge-Frisby, National Drug Research Institute, Burnet Institute, Australia
  • Troy Combo, Burnet Institute, Australia
  • Brian Conway, Vancouver Infectious Diseases Centre, Canada
  • Sean Cox, The Hepatitis C Trust, United Kingdom
  • Sione Crawford, Harm Reduction Victoria, Australia
  • Evan Cunningham, Kirby Institute, Unsw Sydney, Australia
  • Olav Dalgard, Akershus University Hospital, Norway
  • Emma Day, INHSU, Australia
  • Louisa Degenhardt, NDARC UNSW, Australia
  • Rosemary Delabre, Coalition PLUS, France
  • Monica Desai, Ukhsa, United Kingdom
  • Jane Dicka, Harm Reduction Victoria, Australia
  • Karim Diop, Cepiad, Senegal
  • Gregory Dore, The Kirby Institute, UNSW Australia, Australia
  • Bridget Draper, Burnet Institute, Australia
  • Benjamin Eckhardt, NYU School of Medicine/Bellevue Hospital, United States
  • Ahmed Elsharkawy, QE Hospital, UK
  • Rachel Epstein, Boston Medical Center, United States
  • Hugo Faria, Ares do Pinhal, Portugal
  • Jordan Feld, University Health Network, Canada
  • Lesley Gallagher, Vancouver Coastal Health, Canada
  • Rosie Gilliver, Kirketon Road Centre, Australia
  • Jason Grebely, The Kirby Institute, UNSW, Australia
  • Nikitah Habraken, INHSU, Australia
  • Behzad Hajarizadeh, Unsw / Kirby Institute, Australia
  • Rachel Halford, The Hepatitis C Trust, United Kingdom
  • Louise Hansford, Hep C U Later (Inclusion MPFT), UK
  • Brendan Harney, Burnet Institute, Australia
  • Melinda Hassall, Australia
  • Jennifer Havens, University Of Kentucky College Of Medicine, United States
  • Jeremy Hayllar, Australia
  • Margaret Hellard, Burnet Institute, Australia
  • Grant Henderson, Department of Health and Social Care, UK
  • Matt Hickman, Professor in Public Health and Epidemiology, United Kingdom
  • Carol Holly, Hepatitis SA, Australia
  • Vivian Hope, PHI, LJMU, England
  • Sharon Hutchinson, Glasgow Caledonian University, Scotland
  • Andi Hüttenmoser, Arud.ch + Ada-zh.ch, Schweiz
  • Will Irving, United Kingdom
  • Ashly Jordan, New York State Office of Addiction Services and Supports, United States
  • Martin Kåberg, Beroendecentrum Stockholm, Sweden
  • Shashi Kapadia, Weill Cornell Medicine, USA
  • Marina Klein, Mcgill University Health Centre, Canada
  • Nadine Kronfli, Mcgill University, Canada
  • Lise Lafferty, UNSW Sydney, Australia
  • Sarah Larney, Université De Montréal, Canada
  • Andrew Lloyd, The Kirby Institute, Australia
  • Lisa Maher, UNSW Sydney / Kirby Institute, Australia
  • Alison Marshall, Unsw / The Kirby Institute, Australia
  • Stefanie Materniak, Centre For Research, Education And Clinical Care Of At-risk Populations (recap), Canada
  • Andrew McAuley, Glasgow Caledonian University, United Kingdom
  • Pascal Melin, SOS Hépatites, France
  • Fadi Meroueh, European Prison Health Federation, France
  • Håvard Midgard, Akershus University Hospital, Norway
  • Koketso Mokubane, SANPUD, South Africa
  • Linda Montanari, EMCDDA, Portugal
  • Leanne Myers, Peer Based Harm Reduction WA, Australia
  • Danil Nikitin, Global Research Institute (GLORI) Foundation, Киргизия
  • Mercy Nyakowa, National AIDs and STI Control Program, Ministry of Health Kenya, Kenya
  • Mim O’Flynn, Kombi Clinic Ltd, Australia
  • Daniel O’Keefe, Burnet Institute, Australia
  • Sigurdur Olafsson, Landspitali University Hospital, Iceland
  • Anne Øvrehus, Department of Infectious Diseases, Odense University Hospital, Denmark
  • Kimberly Page, University Of New Mexico Health Sciences Center, United States
  • Adam Palayew, Canada
  • Norah Palmateer, Glasgow Caledonian University/health Protection Scotland, Scotland
  • Alisa Pedrana, Burnet Institute, Australia
  • Erica Peters, Nhs Greater Glasgow And Clyde, UK
  • Tim Rhodes, University Of New South Wales, Australia
  • Jacqui Richmond, Burnet Institute, Australia
  • Elana Rosenthal, Institute of Human Virology, University of Maryland School of Medicine, United States
  • Perrine Roux, Sesstim, France
  • Rachel Sacks, Australia
  • Sahar Saeed, Australia
  • Ahmed Mohamed Said, Kwale Network of People Who Use Drugs, Kenya
  • Andrew Scheibe, TB HIV Care, South Africa
  • Sophia Schroeder, Burnet Institute, Australia
  • Andrew Seaman, Oregon Health And Sciences University / Central City Concern, United States
  • Yumi Sheehan, The Kirby Institute, UNSW SYDNEY, Australia
  • Sonjelle Shilton, FIND, Switzerland
  • Marietta Simonova, Klinikum Klagenfurt Am Wörthersee, Austria
  • Thembinkosi Singwane, University of Limpopo, South Africa
  • Mat Southwell, Euronpud, United Kingdom
  • Ashleigh Stewart, Burnet Institute, Australia
  • Jack Stone, University Of Bristol, United Kingdom
  • MJ Stowe, Kirby Institute, University Of New South Wale, Australia
  • Tracy Swan, Freelance/INHSU Board, Spain
  • Vana Sypsa, National And Kapodistrian University Of Athens, Greece
  • Lara Tavoschi, University of Pisa, Italia
  • Kirsten Trayner, Glasgow Caledonian University/Public Health Scotland, United Kingdom
  • Carla Treloar, UNSW Sydney, Australia
  • Heather Valerio, The Kirby Institute, Australia
  • Peter Vickerman, University Of Bristol, UK
  • Jason Wallace, Scottish Drugs Forum, United Kingdom
  • Lili Warren, New York